News

Hookipa is awarded a grant from the Austrian Research Promotion Agency

Vienna (Austria), September 18, 2012 - Hookipa Biotech AG, an Austrian based biotech company today announced the award...

Intercell announces Phase I results on its Vaccine Enhancement Patch (VEP) with Pandemic Influenza antigens

•The co-administration of an A/H5N1 antigen via intramuscular administration (IM) with VEP met two of three CHMP...

Mediatum Top-Management-Studie 2012

Sorry, this entry is only available in German!

SANOCHEMIA - Synthetisches Galantamin für den Weltmarkt

Sorry, this entry is only available in German!

Pharmig: Medizinischer Fortschritt braucht Forschung

Sorry, this entry is only available in German!

GMI: Pflanzenforschung: Genomstabilität in Ei- und Spermazellen

Sorry, this entry is only available in German!

LISAvienna News

Celebrating ten years of LISAvienna - the Vienna Life Science Cluster!

Ten years of successful progress: Life Sciences in Vienna

Intercell’s partner Biological E. Ltd. launches Japanese Encephalitis vaccine JEEV® in India

» Novel vaccine to protect children and adults from Japanese Encephalitis (JE), manufactured by partner Biological E....

IMP: The Biology of Emotions

Neurobiologist Wulf Haubensak, Group Leader at the Research Institute of Molecular Pathology (IMP) in Vienna, has been...